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Combined administration of transcranial direct current-stimulation (tDCS) with either per-
golide (PER) or d-cycloserine (d-CYC) can prolong the excitability-diminishing effects of
cathodal, or the excitability enhancing effect of anodal stimulation for up to 24 h poststim-
ulation. However, it remains unclear whether the potentiation of the observed aftereffects
is dominated just by the polarity and duration of the stimulation, or the dual application
of combined stimulation and drug administration. The present study looks at whether the
aftereffects of oral administration of PER (a D1/D2 agonist) or d-CYC (a partial NMDA recep-
tor agonist), in conjunction with the short-duration antagonistic application of tDCS (either
5 min cathodal followed immediately by 5 min anodal or vice versa), that alone only induces
short-lasting aftereffects, can modulate cortical excitability in healthy human subjects, as
revealed by a single-pulse MEP (motor-evoked-potential) paradigm. Results indicate that
the antagonistic application of tDCS induces short-term neuroplastic aftereffects that are
dependent upon the order of the application of short-duration stimulation. The administra-
tion of d-CYC resulted in a marked inhibition of cortical excitability under the application of
tDCS in both stimulation orders. Intake of PER resulted in an increase in cortical excitability
in both stimulation orientations, but was non-significant compared to the placebo condi-
tion. These results indicate that the aftereffects of tDCS are dependent upon the order
of stimulation applied, and also demonstrate the prolongation of tDCS aftereffects when
combined with the administration of CNS active drugs.
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INTRODUCTION
The effect that transcranial direct current-stimulation (tDCS)
exerts on the intact human cortex is closely related to the mod-
ulation of cortical excitability and neuronal activity, which are
key mechanisms for learning and memory processing (Paulus,
2004). The relevant stimulation parameters encompass the polar-
ity, the current strength, size of the stimulated area, and dura-
tion of the stimulation (Nitsche et al., 2008; Stagg and Nitsche,
2011) and are considered to be safe as assessed by several stud-
ies (Nitsche et al., 2003b; Iyer et al., 2005; Poreisz et al., 2007).
The most common way to evaluate changes in cortical excitabil-
ity is by applying transcranial magnetic stimulation (TMS) to the
motor cortex, since it allows the measurement of reproducible
and quantifiable effects through the analysis of motor-evoked-
potentials (MEPs). Anodal stimulation increases the amplitude
of MEPs while cathodal stimulation decreases them (Nitsche and
Paulus, 2000, 2001). The primary effect of tDCS is a neuronal
de- or hyperpolarization of the membrane potential (Creutzfeldt
et al., 1962; Bindman et al., 1964), whereby the induced afteref-
fects depend on N -methyl-d-aspartate (NMDA) receptor-efficacy
changes (Liebetanz et al., 2002). Studies investigating the com-
bined administration of pharmacological agents combined with
tDCS, has provided valuable insights into the mechanisms and
modes of action that tDCS exerts on neuronal tissue (for a review,
see Nitsche, 2005).
The anatomical structure of the cortex means that when using
currents to polarize neuronal tissue in the brain, a homogeneous
induction of either excitability increase or decrease is prevented
by the folded cortex. If for example, current flows through a cor-
tical gyrus, on one side of the gyrus wall an excitability increase is
induced, whereas on the opposing side, a excitability diminution
cannot be avoided (Creutzfeldt et al., 1962; Lang et al., 2005; Datta
et al., 2009). This is a consideration when utilizing tDCS as treat-
ment in neurological disorders, such as epilepsy, as any unwanted
excitability increases may theoretically worsen seizure frequency
or intensity. The aim of the present study was to find a pharmaco-
logical solution for this problem by investigating whether we were
able to induce changes in cortical excitability using short-duration
antagonistic applications of tDCS in combination with CNS active
drugs that have been shown to prolong neuroplasticity-inducing
aftereffects.
To investigate this question, we stimulated the motor cor-
tex in two opposing directions during one stimulation applica-
tion in addition to administering d-cycloserine (d-CYC) a drug
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selectively prolonging the excitability enhancement induced by
anodal stimulation) or pergolide (PER; a drug selectively pro-
longing the excitability reduction induced by cathodal stimu-
lation) as well as a placebo (PLC) control. After drug intake,
a 5-min anodal followed by a 5-min cathodal (or vice versa)
antagonistic stimulation was applied to the primary motor cor-
tex (M1) in a healthy participant population. Previous studies
proved that 5 min stimulation duration alone did not evoke after-
effects lasting longer than 5 min (Nitsche and Paulus, 2000). A
study by Nitsche et al. (2004a) showed that d-CYC, a partial
NMDA agonist, selectively potentiated the duration of motor-
cortical excitability enhancements induced by anodal tDCS from
approximately 1 h up to 24 h poststimulation without affect-
ing cathodal inhibition. In contrast, PER, a combined D1/D2
receptor agonist, prolonged the excitability-diminishing effects of
cathodal tDCS for up to 24 h after stimulation (Nitsche et al.,
2006).
d-CYC was initially introduced as a tuberculostatic agent
(Walker and Murdoch, 1957) and was later found to be a CNS
active drug at very low doses. d-CYC acts at the glycine-binding
site of the NMDA receptor, thus facilitating the opening of the
NMDA channel (Thomas et al., 1988). In slice preparations, it
has been shown that the activation of this subunit is of impor-
tance for inducing long-term potentiation (LTP) effects, and that
d-CYC can enhance LTP-like neuroplastic effects (Watanabe et al.,
1992).
PER, a D1/D2 dopamine receptor agonist, has been shown
to have effects on intracortical excitability in the human motor
cortex, where it enhanced intracortical inhibition (Ziemann
et al., 1996). A more recent study showed that PER consoli-
dated excitability decreases generated by applications of tDCS to
the M1, up until the morning after stimulation. Furthermore,
co-administration of PER and sulpiride, allowing for D1 acti-
vation in the presence of D2 receptor blocking, was not able
to re-establish the characteristic alterations in cortical excitabil-
ity induced by transcranial direct currents. In another study,
PER was shown to enhance the effect of tDCS (or in particular
cathodal tDCS) in reducing the amplitude of laser-evoked pain
potentials applied over the human M1 (Terney et al., 2008). In
this study, PER was administered to 12 healthy subjects before
tDCS, after assessing subjective acute pain perception induced
by a Tm:YAG laser. The amplitudes of the N2 component of
the laser-evoked pain potentials, as well as the subjective rating
scores, were significantly reduced up to 2 h poststimulation, with
PER increasing the efficacy of the effect of the cathodal stimu-
lation for up to 24 h poststimulation. These data strongly argue
for the importance of D2 receptor activity for the induction of
increases and decreases in prolonged NMDA receptor depen-
dent motor-cortical excitability shifts in humans, as well as a
role in the induction of neuroplastic effects in the intact human
cortex.
The hypothesis central to this exploratory study was to pursue
whether in a paradigm of antagonistic tDCS current flow direc-
tion, the choice of either drug shown to potentiate neuroplastic
effects in the cortex will finally determine the direction of tDCS




Eight healthy subjects participated in each experiment (six male;
mean age 25.5). All gave written informed consent. The study was
approved by the ethics committee of the University of Göttingen,
and conformed to the Declaration of Helsinki.
CURRENT-STIMULATION OF THE MOTOR CORTEX
Direct currents were transferred via a pair of saline-soaked sur-
face sponge electrodes (35 cm2) fixed to the scalp and delivered by
a specially developed battery-driven constant current stimulator
(NeuroConn, Ilmenau, Germany). The motor-cortical electrode
was placed over the representational field of the right abductor
digiti minimi muscle (ADM) as identified by TMS, and the other
electrode was located contralateral to the right orbit. In the dif-
ferent experiments, the currents flowed continuously for 10 min
(5 min anodal+ 5 min cathodal or vice versa) with an intensity of
1.0 mA.
PHARMACOLOGICAL INTERVENTIONS
d-CYC (100 mg), PER (0.025 mg; combined with 10 mg domperi-
done to avoid nausea) or equivalent placebo (PLC) drugs were
administered to the subjects orally 2 h prior to the onset of stim-
ulation. By these means, the verum drugs were able to induce a
stable plasma level (Deleu et al., 2002) and produce prominent
effects in the CNS (Nitsche et al., 2004a, 2006; Kuo et al., 2008).
To avoid interference of plasticity induction by cumulative drug
effects, each experimental session was separated by at least 1 week.
Both the subjects and the investigator conducting the experiment
were blinded as to the respective pharmacological and stimulation
conditions administered during each experimental session.
MEASUREMENT OF MOTOR-CORTICAL EXCITABILITY
To detect current-driven changes of excitability, motor-evoked
potentials (MEPs) of the right ADM were recorded following stim-
ulation of its motor-cortical representational field by single-pulse
TMS. These were induced using a Magstim 200 magnetic stim-
ulator (Magstim, Whiteland, Dyfed, UK) and a figure-of-eight
magnetic coil (diameter of one winding= 70 mm; peak magnetic
field= 2.2 T). The coil was held tangentially to the skull, with the
handle pointing backward and laterally at 45˚ from the midline.
The optimal position was defined as the site where stimulation
resulted consistently in the largest MEP. Surface EMG was recorded
from the right ADM by use of Ag–AgCl electrodes in a belly tendon
montage. Raw signals were amplified, band-pass filtered (2–3 kHz;
sampling rate, 5 kHz), digitized with a micro 1401 AD converter
(Cambridge Electronic Design, Cambridge, UK) controlled by Sig-
nal Software (Cambridge Electronic Design, version 2.13), and
stored on a personal computer for offline analysis. The intensity
of the stimulator output was adjusted for baseline recording so
that the average stimulus led to an MEP of ∼1 mV.
EXPERIMENTAL PROCEDURES
The experiments were conducted in a randomized, repeated mea-
surement design. The subjects were seated in a reclining chair.
First, the left motor-cortical representational field of the right
ADM was identified by use of TMS (coil position that leads to
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the largest MEPs of ADM). Then one DC stimulation electrode, to
which in the following the terms cathodal or anodal stimulation
refer, was fixed at this position, and the other one was fixed at the
contralateral forehead above the orbit.
A baseline of TMS-evoked MEPs (60 stimuli) was recorded
at 0.25 Hz. Afterward, anodal, cathodal, or sham tDCS was per-
formed for 10 min. After termination of tDCS, 60 MEPs were
recorded at 0.25 Hz 0, 5, and then every 10 min up to 60 min
poststimulation.
STATISTICAL ANALYSIS
MEP amplitude means were calculated for each time bin covering
baseline (60 stimuli) and poststimulation time-points (60 stimuli).
These were normalized and are given as ratios of the pre-current
baselines.
Separate repeated measurement anovas [independent vari-
ables time course, current-stimulation (TYPE: anodal-cathodal
or anodal-cathodal), drug condition (PLC vs. d-CYC or PPER),
dependent variable MEP amplitude) were calculated for each time
bin up to 60 min post-tDCS, for the different stimulation condi-
tions separately. Student’s t -tests (paired samples, two-tailed, level
of significance<0.05) were performed at each time point to deter-
mine whether the MEP amplitudes differed with regard to placebo
or the drug administration.
RESULTS
None of the subjects reported any adverse events during and after
the experiments.
PLACEBO ADMINISTRATION
The cortical excitability change depended on the application
of the second type of stimulation: the anodal-cathodal stim-
ulation resulted in a decrease in cortical excitability while the
cathodal-anodal stimulation produced excitation (Figures 1A,B).
The ANOVA revealed no significant main effect with regard to the
TYPE of stimulation [F(1, 14)= 1.46, p= 0.24] and time course
[F(7, 98)= 0.91,p= 0.5] but the interaction of the TYPE of stimu-
lation× time course showed a tendency [F(7, 98)= 1.8; p= 0.06].
Student’s t -test showed a significant difference at 5′ and 10′ post-
stimulation between the anodal-cathodal and cathodal-anodal
stimulation conditions (p< 0.05, t = 2.54; 2.4).
CATHODAL-ANODAL CURRENT DIRECTION
After d-CYC administration there was a decrease in corti-
cal excitability using the cathodal-anodal stimulation order
(Figure 1). Compared to the PLC stimulation, the anova revealed
significant main effect of stimulation [F(1, 14)= 5.97, p= 0.03],
but the time course [F(7, 98)= 0.86, p= 0.53] and the interac-
tion of stimulation× time course [F(7, 98)= 0.89, p= 0.51] were
not significant. The Student t -test showed a significant excitability
decrease at 10, and 20 min poststimulation compared to placebo
intake (p< 0.05, t = 3.13; 2.46).
After PER administration there was no detectable after-effect
when the cathodal-anodal stimulation combination was applied.
Generally, the MEP amplitudes were more unstable compared to
the other stimulation condition. Compared to the PLC adminis-
tration, the anova revealed no main effect of stimulation [F(1,
FIGURE 1 | Effects of antagonistic cathodal-anodal (A) and
anodal-cathodal (B) tDCS in conjunction with PER, CYC, and PLC
control. MEP amplitudes are given as mV, vertical bars indicate SEM. With
regard to the PLC condition the order of each short-duration antagonistic
tDCS application is the predominating factor in modulating short-duration
tDCS aftereffects. A tendency toward excitability enhancement was seen
after PER administration in the cathodal-anodal stimulation order. After
anodal-cathodal tDCS an increase in cortical excitability is also evident, but
was not significant. d-CYC administration resulted in a decrease in cortical
excitability regardless of the orientation of stimulation.
14)= 1.98, p= 0.16] and time course [F(7, 98)= 1.02, p= 0.41]
and no significant interaction of stimulation× time course [F(7,
98)= 1.14, p= 0.32].
ANODAL-CATHODAL CURRENT DIRECTION
However, after d-CYC administration there was no significant
change in cortical excitability using the anodal-cathodal stim-
ulation order. There was no significant main effect of stimula-
tion [F(1, 14)= 0.19, p= 0.66] and time course [F(7, 98)= 1.54,
p= 0.16]. The interaction between the type of stimulation and
time course was not significant [F(7, 98)= 0.43,p= 0.8; Figure 1].
Similarly, after PER administration there was no significant
aftereffect when the anodal-cathodal stimulation combination was
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applied. Generally, the MEP amplitudes were more unstable com-
pared to the other stimulation condition. Compared to the PLC
administration, the anova revealed no main effect of stimula-
tion [F(1, 14)= 0.19, p= 0.82] and time course [F(7, 98)= 1.43,
p= 0.19] and no significant interaction of stimulation× time
course [F(7, 98)= 0.67, p= 0.79].
DISCUSSION
This investigation into the antagonistic application of tDCS
revealed that the order of each tDCS primarily determines the
induced aftereffects; which was either an increase or decrease
in cortical excitability. Initially our hypothesis was to examine
whether the administration of a pharmacological agent known to
modulate neuroplastic effects in the cortex, would influence the
direction of induced aftereffects and/or prolong any measureable
aftereffects. We observed that there was no excitatory afteref-
fect after d-CYC administration for both the cathodal-anodal
and anodal-cathodal stimulation orders (only an inhibition was
observed), and no inhibitory after-effect after PER administration,
irrespective of the current flow direction sequence. A prolonga-
tion of tDCS aftereffects outlasting the stimulation duration of
5 min in each polarity (anodal or cathodal tDCS) was observed.
In a previous study, Nitsche and Paulus (2000) demonstrated
that short-duration tDCS (5 and 7 min) did not produce after-
effects lasting longer than between 5 and 30 min (depending upon
the stimulation duration), whereas the present study reports that
10 min of antagonistic tDCS produces at least a 10-min aftereffect
post-drug administration. In addition, we observed that the order
of stimulation was the dominant modulator of the tDCS-induced
aftereffect. For example, when 5 min cathodal-anodal stimulation
was applied over the M1, a net excitatory effect was observed,
and vice versa for the reverse stimulation combinations for the
PLC condition. For the cathodal-anodal stimulation order, there
was a net decrease in cortical excitability under d-CYC which
showed a significant interaction between the order of stimulation
across the measured timecourse (at 5 and 10 min) poststimula-
tion. The administration of PER showed an overall increase in
MEP amplitudes but was not significant compared to the PLC
condition. In the anodal-cathodal stimulation order, d-CYC and
the PLC showed a decrease in cortical excitability over time but
this tendency was not significant. PER increased MEP amplitudes
compared to the PLC condition, but this was also not significant.
The MEPs recorded under PER administration in both stimula-
tion orders were largely unstable and so a significant net increase
or decrease in the levels of cortical excitability was difficult to
determine. The mechanism of tDCS action has been investigated
in many previous human and animal studies (Bindman et al.,
1964; Nitsche, 2005; Nitsche et al., 2005) and has also been well
characterized by the use of CNS active drugs (Nitsche, 2005). Dur-
ing tDCS, the effects of both anodal and cathodal stimulation are
dependent upon fluctuations in membrane potential. However,
the induction of tDCS aftereffects can also depend upon synap-
tic modulation and affect intracortical neurons (as anodal and
cathodal DC currents do not influence motor threshold values;
Nitsche et al., 2005). The aftereffects of anodal and cathodal tDCS
are influenced by the potentiation of receptors at the glutamater-
gic synapse (Nitsche et al., 2003a), and studies have also shown
that they are modulated by dopamine, acetylcholine, and sero-
tonin receptors (Kuo et al., 2007; Monte-Silva et al., 2009; Nitsche
et al., 2009). Anodal tDCS is also strongly influenced by GABAer-
gic neurotransmission via the activity of interneurons (Nitsche
et al., 2004b). The relatively weak effects of antagonistic tDCS that
we have observed in this study may arise for a number of differ-
ent reasons; the balance between the potentiation of D1 and D2
receptors by PER and the low dosage administered may account
for the unstable trend toward cortical excitation. Sampling a larger
subject group could also have reduced the high variability in the
MEP data and also have made this trend significant. Secondly,
the effects of tDCS alone showed that the order of each stimu-
lation application influenced that outcome of the aftereffects. As
tDCS is duration dependent, it is also possible that the stimula-
tion duration was not long enough to induce enduring aftereffects.
The interaction between PER,d-CYC, and tDCS at the membrane
would also have affected the stability of the aftereffects, as tDCS-
induced neuroplasticity is NMDA receptor dependent (Liebetanz
et al., 2002) and influenced by the ratio of D1/D2 receptors; the
potentiation of NMDA receptors may not have been strong enough
to overcome the effects of the short-lasting DC modulations. In
summary, tDCS aftereffects are dependent upon the polarity of
stimulation, duration, and intensity, but are also heavily influenced
by neuromodulators potentiating receptors that are present upon
the neuronal membrane. Therefore, it is difficult point out a sin-
gle mode of action that is responsible for the aftereffects observed
here.
The effects of antagonistic tDCS have not been widely investi-
gated until now. Priori et al. (1998), whilst looking at DC polariza-
tion of the motor cortex, reported that pulses of anodal DC only
changed the amplitude of elicited MEPs when there was an alter-
nation in the application of anodal and cathodal DC. Based upon
animal data (Stafstrom et al., 1984), they suggested that there may
be a degree of neuronal adaptation, whereby neuronal elements
compensate for the DC-induced changes in the membrane poten-
tial. This indicated that by alternating the anodal-cathodal DC
sequence, the targeted neuronal elements were prevented from
adapting to the polarizing DC stimulation.
We were able to observe a significant inhibition in cortical
excitability when tDCS in the cathodal-anodal current direction
was applied under d-CYC administration. These results are similar
to the data published by Kuo et al. (2008). The combined appli-
cation of cathodal-anodal tDCS and d-CYC within independent
experimental sessions, were examined in conjunction with mech-
anisms of homeostatic plasticity during a motor learning task.
The excitability diminution induced by cathodal tDCS prior to
motor learning, or an excitability enhancement induced by anodal
tDCS if combined with the partial NMDA receptor agonist d-CYC,
impaired learning performance. Similarly to these data, we have
observed a decrease in MEP amplitude, when the cathodal-anodal
stimulation condition was applied. However, the stimulation dura-
tion was shorter compared to those applied in previous studies
with d-CYC, which may account for the differences reported in
this study.
In our study, the oral administration of PER did not induce any
significant aftereffect poststimulation, and the results were not sig-
nificantly different from those obtained under the PLC condition
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although a tendency toward excitability enhancement could be
seen. This was possibly due to the increased variability of MEP
amplitudes after PER intake. We have seen that administration of
PER increased the instability of MEPs (and thus the variability of
MEP amplitudes) after the antagonistic administration of tDCS.
The possible cause of this instability could be attributed to the very
low dose of PER given in this study, compared to those of other
studies reporting the effects of PER on transcranial stimulation
measured using TMS-elicited MEPs (Lang et al., 2008). As previ-
ously mentioned, the variability may also have been decreased by
increasing the number of participants that were involved in the
study.
Dopaminergic (DA) mechanisms have been demonstrated to
stabilize these processes involved in neuroplasticity induction (for
a review examining the effects of dopamine on cortical excitabil-
ity, see Nitsche et al., 2010). DA acting on D1 receptors increases
NMDA currents (Cepeda and Levine, 1998). In addition, the
enhancement of D2 – and to a lesser degree – of D1 receptors
by pergolide consolidated tDCS generated excitability diminution
up until the morning post stimulation (Nitsche et al., 2006). A
number of recent studies have looked at the interaction of the
dopaminergic system with tDCS applied to the cortex. One study
examining the dose-dependent effects of dopamine on plastic-
ity processes employed two varying methods to either induce
focal (paired-associative stimulation, PAS) or non-focal (tDCS
paradigms) plasticity in the motor cortex. The authors demon-
strated that administration of varying dosages of ropinirole, a
D2/D3 dopamine agonist, resulted in an inverted “U”-shaped
dose-response curve on excitability enhancing tDCS and PAS pro-
tocols, as well as inhibitory tDCS protocols. They concluded that
in high or low dosages, ropinirole attenuated plasticity-inducing
processes, and that neuroplasticity processes involving D2 recep-
tor potentiation are subject to dose-dependent effects, and can
be considered when examining inhibitory and facilitatory mecha-
nisms of plasticity, depending upon the type of plasticity induced
(Monte-Silva et al., 2009). A similar study showed that l-dopa
administered in high (200 mg) or low (25 mg) doses abolished
facilitatory and inhibitory cortical plasticity, whereas a medium
dose (100 mg) reversed facilitation into inhibition in the motor
cortex, as well as prolonging inhibitory plasticity (Monte-Silva
et al., 2010). Investigations into the impact of dopamine on learn-
ing and memory formation demonstrate that dopamine also has
a focusing effect on neuroplasticity processes. A study looking at
the influence of D1 receptors showed that the balance between
D1 and D2 receptor activity is crucial in both the consolidation
of resultant excitability changes arising from non-focal (tDCS)
and focal (PAS; in this case inhibitory, iPAS, or excitatory, ePAS),
neuroplasticity-inducing paradigms, and to generate a focusing
effect of plasticity (Nitsche et al., 2009). The possible mechanisms
of DC-induced aftereffects were investigated in several previous
studies; pharmacological intervention suggests that the aftereffect
isN -methyl-d-aspartate (NMDA)-receptor dependent (Liebetanz
et al., 2002; Nitsche et al., 2004a,b,c). NMDA receptor and intracel-
lular sigma 1 receptor blocker dextromethorphan intake prevented
both anodal and cathodal tDCS-induced aftereffects, demonstrat-
ing that dextromethorphan critically interferes with the function-
ality of tDCS irrespective of the polarity of the DC stimulation.
It is known that long-lasting NMDA receptor dependent cortical
excitability and activity shifts are involved in neuroplastic modi-
fication. Another study revealed that NMDA receptor antagonist
dextromethorphan did not changes levels of cortical excitability
during a short-duration of tDCS, and also prevented any enduring
aftereffects of tDCS, independent of stimulation polarity (Nitsche
et al., 2003a).
Homeostatic mechanisms are might also play a role in the
observable aftereffects of tDCS, a state whereby neurons in the
nervous system dynamically adjust synaptic strengths favoring
the direction that promotes stability in growing networks. This
process is not unlike Hebbian mechanisms of plasticity, but dif-
fers fundamentally in the sense that Hebbian mechanisms tend to
destabilize neural circuits and homeostatic mechanisms can relate
complex neural networks responsible for processes ranging from
memory storage to activity dependent development, and so by
their very nature are more stable (Turrigiano and Nelson, 2000,
2004). Preconditioning the M1 with tDCS can shape the magni-
tude and direction of excitability changes induced by a subsequent
session of repetitive TMS (rTMS). Lang et al. (2004) published a
study demonstrating that anodal tDCS causes a subsequent appli-
cation of 1 Hz rTMS to reduce corticospinal excitability, while
preconditioning with cathodal tDCS induces the reverse effect.
However, our present data are not in agreement with these previ-
ous results, suggesting that for the manifestation of homeostatic
mechanisms longer stimulation durations may be required, or that
this kind of plasticity has a limited influence when more compo-
nents (drug application and antagonistic external stimulation) are
administered at the same time.
In this exploratory investigation, we are able to reveal that stim-
ulation duration has a much greater impact on modulating cortical
excitability than the administration of sub-therapeutic levels of
CNS active drugs, in combination with tDCS. Further experi-
mental work would need to be conducted in order to understand
whether it was initially the use of a shorter stimulation duration in
this antagonistic stimulation sequence, or the antagonistic admin-
istration of tDCS in combination with PER or d-CYC that may
have resulted in the aftereffects that we report here; this may be
the critical limiting step within the paradigm that we have chosen
to implement in this study. Previous studies have highlighted the
efficacy of non-invasive brain stimulation devices used in com-
bination both with and without CNS drugs in the treatment of
neurological disorders, for example in the treatment of chronic
pain (Antal and Paulus, 2011), migraine (Antal et al., 2011), and
depression (Loo et al., 2012). With this study we aimed to investi-
gate whether the antagonistic application of tDCS in combination
with PER and d-CYC could induce changes in cortical excitability,
and modulate these excitability changes long enough to provide
an insight into whether short-duration tDCS could be used as a
therapeutic approach for neurological disturbances.
CONCLUSION
The present study reports that administration of CNS active drugs
in combination with short-duration tDCS can modulate tDCS-
induced aftereffects in the healthy human motor cortex. The
predominant factor influencing the outcome of these effects is
the order of antagonistic short-duration tDCS application.
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